Nexalin Technology Inc NXL

$5.73 -1.82 (-24.11%)

Valuation

Market cap
4,205,000
Revenue TTM
$300,000
Net income TTM
$-8,220,000
PE ratio
0.00
Forward PE
—
Profit margin
-2,740.00%
Debt to equity
0.00

Trading

Volume
1,366,300
Avg volume
1,284,973
Day's range
$5.15 – $5.95
Shares out
734,000
Stochastic %K
24%
Beta
4.08
Analysts
Sell
Price target
$60.00

Price

Company profile

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 heads...

Show more

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Industry
Medical Devices
Sector
Healthcare
Phone
832 260 0222
Website
https://www.nexalin.com
Address
1776 Yorktown, Suite 550, Houston, United States

Latest news

No headlines yet.